APA (7th ed.) Citation

Pio López, Eduardo López-Medina, Xavier Sáez-Llorens, Rodrigo deAntonio, Taisei Masuda, Paul M. Mendelman, . . . Astrid Borkowski. (2023). Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Pio López, Eduardo López-Medina, Xavier Sáez-Llorens, Rodrigo deAntonio, Taisei Masuda, Paul M. Mendelman, James Sherwood, Frank Baehner, and Astrid Borkowski. Immunogenicity and Tolerability of a Bivalent Virus-like Particle Norovirus Vaccine Candidate in Children from 6 Months Up to 4 Years of Age: A Phase 2 Randomized, Double-blind Trial. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Pio López, et al. Immunogenicity and Tolerability of a Bivalent Virus-like Particle Norovirus Vaccine Candidate in Children from 6 Months Up to 4 Years of Age: A Phase 2 Randomized, Double-blind Trial. Taylor & Francis Group, 2023.